These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy. Pessôa MG, Gazzard B, Huang AK, Brandão-Mello CE, Cassetti I, Mendes-Corrêa MC, Soriano V, Phiri P, Hall A, Brett-Smith H. AIDS; 2008 Sep 12; 22(14):1779-87. PubMed ID: 18753861 [Abstract] [Full Text] [Related]
24. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC. Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088 [Abstract] [Full Text] [Related]
25. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir. Matthews GV, Cooper DA, Dore GJ. Antivir Ther; 2007 Nov 01; 12(1):119-22. PubMed ID: 17503756 [Abstract] [Full Text] [Related]
26. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, Lewin SR. J Virol; 2005 Mar 01; 79(5):3038-51. PubMed ID: 15709024 [Abstract] [Full Text] [Related]
32. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. Dore GJ, Cooper DA, Pozniak AL, DeJesus E, Zhong L, Miller MD, Lu B, Cheng AK, 903 Study Team, 907 Study Team. J Infect Dis; 2004 Apr 01; 189(7):1185-92. PubMed ID: 15031786 [Abstract] [Full Text] [Related]
37. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Levy V, Grant RM. Clin Infect Dis; 2006 Oct 01; 43(7):904-10. PubMed ID: 16941375 [Abstract] [Full Text] [Related]
39. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection. Schmutz G, Nelson M, Lutz T, Sheldon J, Bruno R, von Boemmel F, Hoffmann C, Rockstroh J, Stoehr A, Wolf E, Soriano V, Berger F, Berg T, Carlebach A, Schwarze-Zander C, Schürmann D, Jaeger H, Mauss S. AIDS; 2006 Oct 03; 20(15):1951-4. PubMed ID: 16988516 [Abstract] [Full Text] [Related]